Newsroom

Sorted by: Latest

-

FFIV Investors Have Opportunity to Lead F5, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--FFIV Investors Have Opportunity to Lead F5, Inc. Securities Fraud Lawsuit with the Schall Law Firm...
-

Money Transfer Apps Market Worth $52 Billion by 2030: Market-Entry and Growth Strategies Through 2026-2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Money Transfer App Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Money Transfer App was valued at US$22.5 Billion in 2024 and is projected to reach US$52 Billion by 2030, growing at a CAGR of 15% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Growth in the money transfer app marke...
-

F5, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against F5, Inc. (NasdaqGS: FFIV), if they purchased or otherwise acquired the Company’s securities between October 28, 2024, and October 27, 2025, inclusive (the “Class Period”). This act...
-

Incyte Japan gibt die Zulassung von Minjuvi® (Tafasitamab) in Kombination mit Rituximab und Lenalidomid zur Behandlung von rezidiviertem oder refraktärem follikulärem Lymphom bekannt

TOKIO--(BUSINESS WIRE)--Incyte Biosciences Japan G.K. gab heute bekannt, dass das japanische Ministerium für Gesundheit, Arbeit und Soziales (MHLW) Minjuvi® (Tafasitamab) in Kombination mit Rituximab und Lenalidomid für erwachsene Patienten mit rezidiviertem oder refraktärem follikulärem Lymphom (2L+ FL) zugelassen hat. „Die heutige Zulassung von Minjuvi in Kombination mit Rituximab und Lenalidomid ist ein bedeutender Meilenstein, da es sich um die erste dual-zielgerichtete CD19- und CD20-Immun...
-

FloWorks Acquires Cranford Equipment Company

ROSEMONT, Ill.--(BUSINESS WIRE)--FloWorks International LLC (“FloWorks”), a leading specialty distributor of critical flow control products and a portfolio company of Wynnchurch Capital, L.P. (“Wynnchurch”), today announced the acquisition of Cranford Equipment Co., Inc. (“CEC” or the “Company”). Headquartered in Kenner, Louisiana, CEC is a distributor of filtration products, serving diverse industrial applications. Scott Jackson, CEO of FloWorks, commented on the transaction, saying, “Bart and...
-

El Un-carrier y su Un-wrapped de 2025

BELLEVUE, Wash.--(BUSINESS WIRE)--Un año tan increíble para T-Mobile que se merece un ¡salud! por todo lo que El Un-carrier ha logrado en el 2025. La compañía se convirtió oficialmente en la Mejor Red del País y alcanzó su trimestre más fuerte en más de una década. Fast Company reconoció que la cultura de T-Mobile desafía el status quo y nos incluyó en su lista de Los mejores entornos laborales para innovadores. La versión beta del servicio directo a celular de T-Satellite con Starlink debutó y...
-

Coherent Solutions schließt strategische Investition unter der Leitung von IceLake ab

MINNEAPOLIS & AMSTERDAM--(BUSINESS WIRE)--Coherent Solutions, ein weltweit tätiges Unternehmen für digitale Technik, hat den Abschluss einer strategischen Investition durch IceLake bekannt gegeben, einen führenden Private-Equity-Investor, der sich auf Partnerschaften mit wachstumsstarken Unternehmensdienstleistern spezialisiert hat. Die Transaktion, die bereits im September 2025 angekündigt wurde, hat nun alle erforderlichen behördlichen Genehmigungen erhalten. Coherent Solutions beschäftigt ru...
-

Investor Notice: Robbins LLP Informs Investors of the SLM Corporation Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who invested in SLM Corporation (NASDAQ: SLM, SLMBP) securities between July 25, 2025 and August 14, 2025. SLM, more commonly known as Sallie Mae, primarily originates and services private education loans (“PELs”) to students and their families. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP...
-

EA Investors Have the Opportunity to Join Investigation of Electronic Arts Inc. with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--EA Investors Have the Opportunity to Join Investigation of Electronic Arts Inc. with the Schall Law Firm...
-

Un-carrier Unwrapped 2025

BELLEVUE, Wash.--(BUSINESS WIRE)--It’s been quite a year for T-Mobile — the kind that makes you want to raise a glass to everything the Un-carrier made possible in 2025. The company officially became America’s Best Network and delivered its strongest quarter in more than a decade. Fast Company named T-Mobile one of the Best Workplaces for Innovators, recognizing a culture built to challenge the status quo. T-Satellite with Starlink made its debut as the beta for direct-to-cell service launched...